医学
重症监护医学
拯救脓毒症运动
重组
衡平法
临床实习
梅德林
败血症
透视图(图形)
全球卫生
循证实践
质量(理念)
循证医学
医疗保健
质量管理
钥匙(锁)
成果研究
病危
系统回顾
生活质量(医疗保健)
卫生专业人员
芯(光纤)
医疗急救
医疗保健系统
风险分析(工程)
作者
M Xue,J F Xie,H B Qiu,L Liu
出处
期刊:PubMed
[National Institutes of Health]
日期:2026-06-30
卷期号:106 (24): 2391-2397
标识
DOI:10.3760/cma.j.cn112137-20260421-01074
摘要
The 2026 Surviving Sepsis Campaign guidelines represent a systematic update built upon the 2021 version. The core changes are reflected not only in the adjustment of clinical recommendations but also, more significantly, in the restructuring of the methodological framework. This article provides an in-depth analysis of the new guidelines across four key dimensions: methodological innovations, evolution of clinical diagnostic and treatment strategies, extension of whole-course management, and the establishment of an independent recommendation system for resource-limited settings. The 2026 guidelines achieve four major paradigm shifts: transitioning from simple evidence updates to methodological restructuring, from uniform recommendations to risk-stratified precision medicine, from acute-phase treatment to whole-course management, and from a high-resource medical center perspective to a global health equity perspective. However, systematically identifying evidence gaps, integrating effective strategies into clinical practice, and placing greater emphasis on patients' long-term functional recovery and life quality remain future research priorities.
科研通智能强力驱动
Strongly Powered by AbleSci AI